Please use this identifier to cite or link to this item: https://repository.monashhealth.org/monashhealthjspui/handle/1/52577
Title: Interplay of age and risk factor control upon coronary atheroma progression.
Authors: Dykun I.;Carlo J.;Nissen S.E.;Kapadia S.R.;Nicholls S.J.;Puri R.
Monash Health Department(s): Cardiology (MonashHeart)
Institution: (Dykun, Carlo, Nissen, Kapadia, Puri) C5Research, Department of Cardiovascular Medicine, Heart, Vascular, and Thoracic Institute, Cleveland Clinic, Cleveland, OH, United States
(Dykun) Department of Cardiology and Vascular Medicine, West German Heart and Vascular Center, University Hospital Essen, Essen, Germany
(Nicholls) Monash Cardiovascular Research Centre, Victorian Heart Institute, Monash University, Melbourne, VIC, Australia
Issue Date: 4-Oct-2024
Copyright year: 2024
Publisher: Elsevier Ltd
Place of publication: United Kingdom
Publication information: Heart Lung and Circulation. (no pagination), 2024. Date of Publication: 2024.
Journal: Heart Lung and Circulation
Abstract: Background & Aim: The extent and composition of coronary plaque, and its progression differ with patients' age. The interplay of patient's age with respect to risk factor control, upon atheroma progression has not been evaluated. We tested the hypothesis that risk factor control modulates the association between age and coronary atheroma progression. Method(s): We performed a post hoc pooled analysis of data from 10 prospective, randomised trials involving serial coronary intravascular ultrasonography (IVUS) (n=5,823). The percent atheroma volume (PAV) was calculated as the proportion of the entire vessel wall occupied by atherosclerotic plaque. Result(s): Mean overall age was 58+/-9 years (28% women). In a fully adjusted multivariable analysis (following adjustment of sex, body mass index, systolic blood pressure [SBP], smoking, high-density lipoprotein and low-density lipoprotein [LDL]-cholesterol, triglyceride levels, peripheral vascular disease, diabetes mellitus, trial, region, and baseline PAV), an increase in age by one standard deviation was linked with PAV progression (beta-estimate 0.097; 95% confidence interval 0.048-0.15; p<0.001). In patients with good risk factor control (LDL-cholesterol <1.8 mmol/L and SBP <130 mmHg), increasing age remained associated with PAV progression (0.123; 0.014-0.23; p=0.027). Lower effect sizes for the association of age with PAV progression were observed for patients with partial control of LDL-cholesterol and SBP and were not significantly associated with PAV progression when both LDL-cholesterol and SBP were not controlled (0.099; 0.032-0.167; p=0.004 and 0.042; -0.056 to 0.14; p=0.40, respectively). Conclusion(s): Patient age is directly associated with coronary atheroma progression independently of traditional cardiovascular risk factors. In the setting of poor risk factor control, the influence of age on coronary artery disease progression is attenuated.Copyright © 2024
DOI: http://monash.idm.oclc.org/login?url=https://dx.doi.org/10.1016/j.hlc.2024.06.1031
PubMed URL: 39358130 [https://www.ncbi.nlm.nih.gov/pubmed/?term=39358130]
URI: https://repository.monashhealth.org/monashhealthjspui/handle/1/52577
Type: Article
Subjects: atheroma
atherosclerotic plaque
coronary artery disease
diabetes mellitus
interventional ultrasonography
peripheral vascular disease
Type of Clinical Study or Trial: Randomised controlled trial
Appears in Collections:Articles

Show full item record

Page view(s)

6
checked on Oct 23, 2024

Google ScholarTM

Check


Items in Monash Health Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.